Kerala's public hospitals face critical shortage of non-communicable disease drugs

Government hospitals across Kerala are grappling with a shortage of medicines used to treat non-communicable diseases (NCDs), posing a challenge to patient care in the state's public healthcare system. The supply crisis stems from delays in the distribution mechanism at Kerala Medical Services Corporation Limited (KMSCL), the nodal agency responsible for procuring and distributing pharmaceuticals to government facilities.

According to hospital administrators, KMSCL released drug supplies for the first quarter as scheduled, but failed to deliver the second batch of medicines due in June. This interruption in the supply chain has left several government hospitals struggling to stock essential NCD medications, including treatments for diabetes, hypertension, and cardiovascular conditions.

NCDs account for a significant disease burden in Kerala, with chronic conditions affecting a large segment of the population. The shortage threatens to disrupt continuity of care for patients dependent on government hospitals for affordable treatment options. Healthcare officials have raised concerns about the impact on vulnerable patient populations who rely exclusively on public healthcare facilities.

The delay in pharmaceutical supplies highlights systemic challenges in Kerala's drug distribution network. Officials from the state health department are expected to address the supply gap urgently to prevent further disruptions to essential healthcare services. The state government has not yet issued an official statement regarding timelines for resolving the shortage or alternative measures being undertaken.